Taxotere + Cisplatin in Nasopharyngeal Carcinoma

NCT00436293 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasopharyngeal Neoplasms

Interventions

DRUG: Docetaxel
DRUG: Cisplatin

Sponsor

Sanofi